Virtu Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,356
| Closed | -$1.17M | – | 2346 |
|
|
2021
Q2 | $1.17M | Buy |
+6,356
| New | +$1.17M | 0.11% | 162 |
|
|
2020
Q3 | – | Sell |
-19,366
| Closed | -$2.17M | – | 1746 |
|
|
2020
Q2 | $2.17M | Buy |
+19,366
| New | +$2.17M | 0.25% | 79 |
|
|
2019
Q4 | – | Sell |
-22,925
| Closed | -$2.25M | – | 1999 |
|
|
2019
Q3 | $2.25M | Buy |
+22,925
| New | +$2.25M | 0.18% | 103 |
|
|
2019
Q1 | – | Sell |
-26,453
| Closed | -$2.58M | – | 2032 |
|
|
2018
Q4 | $2.58M | Buy |
+26,453
| New | +$2.58M | 0.14% | 92 |
|
|
2017
Q4 | – | Sell |
-15,923
| Closed | -$2.23M | – | 3233 |
|
|
2017
Q3 | $2.23M | Buy |
+15,923
| New | +$2.23M | 0.11% | 150 |
|
|
2016
Q4 | – | Sell |
-2,373
| Closed | -$291K | – | 600 |
|
|
2016
Q3 | $291K | Buy |
+2,373
| New | +$291K | 0.05% | 278 |
|
|
2016
Q1 | – | Sell |
-2,964
| Closed | -$565K | – | 543 |
|
|
2015
Q4 | $565K | Buy |
+2,964
| New | +$565K | 0.08% | 212 |
|
|
2015
Q3 | – | Sell |
-3,153
| Closed | -$570K | – | 418 |
|
|
2015
Q2 | $570K | Buy |
+3,153
| New | +$570K | 0.05% | 192 |
|
|
2015
Q1 | – | Sell |
-1,776
| Closed | -$329K | – | 411 |
|
|
2014
Q4 | $329K | Sell |
1,776
-163
| -8% | -$30.2K | 0.04% | 228 |
|
|
2014
Q3 | $322K | Buy |
+1,939
| New | +$322K | 0.03% | 210 |
|
|
2014
Q2 | – | Sell |
-3,506
| Closed | -$533K | – | 471 |
|
|
2014
Q1 | $533K | Buy |
3,506
+1,748
| +99% | +$266K | 0.07% | 189 |
|
|
2013
Q4 | $234K | Buy |
+1,758
| New | +$234K | 0.02% | 210 |
|